Stoke Therapeutics, Inc. (STOK)

NASDAQ: STOK · Real-Time Price · USD

11.59

+0.02 (0.17%)

At close: Jun 20, 2025, 4:00 PM

11.58

-0.01 (-0.09%)

After-hours: Jun 20, 2025, 4:20 PM EDT

Revenue by Product

Fiscal year is January - December.

Fiscal Year	FY 2023	FY 2022
Period Ending	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022
Antisense Oligonucleotide	8.78M	Log In
Antisense Oligonucleotide Growth	-29.22%	Log In

Revenue by Geography

Fiscal year is January - December.